MetaADEDB 2.0 @ LMMD
Formyl 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-3,3,5-triformylpiperazin-1-yl]ethoxy]-2-formyl-3-oxopropanoate
(XTICFBNNDZNSDH-UHFFFAOYSA-N)
Structure
SMILES
O=COC(=O)C(OCCN1CC(C=O)N(C(C1)(C=O)C=O)C(c1ccc(cc1)Cl)c1ccccc1)(C=O)C=O
Molecular Formula:
C27H25ClN2O9
Molecular Weight:
556.948
Log P:
1.1156
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
0
TPSA:
144.43
CAS Number(s):
N/A
Synonym(s)
1.
Formyl 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-3,3,5-triformylpiperazin-1-yl]ethoxy]-2-formyl-3-oxopropanoate
External Link(s)
PubChem Compound129629050
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Alanine Aminotransferase IncreasedFAERS: 1US FAERS
2AphasiaFAERS: 1US FAERS
3ArthralgiaFAERS: 1US FAERS
4Atrioventricular BlockFAERS: 1US FAERS
5Blood pressure fluctuationFAERS: 1US FAERS
6Chest discomfortFAERS: 1US FAERS
7CholangitisFAERS: 1US FAERS
8Depressed moodFAERS: 1US FAERS
9DizzinessFAERS: 1US FAERS
10FatigueFAERS: 1US FAERS
11Feeling ColdFAERS: 1US FAERS
12Feeling abnormalFAERS: 1US FAERS
13Fluid imbalanceFAERS: 1US FAERS
14HypersensitivityFAERS: 1US FAERS
15HyperventilationFAERS: 1US FAERS
16Poor quality sleepFAERS: 1US FAERS
17SyncopeFAERS: 1US FAERS
18TinnitusFAERS: 1US FAERS
19Transaminases increasedFAERS: 1US FAERS
20Walking aid userFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.